DHR vs TTD: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Trade Desk, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
The Trade Desk, Inc. · Communication Services
$18.51
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
TTD has more upside to fair value
(+45.0%).
TTD trades at a lower forward P/E
(20.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TTD |
| Current Price |
$177.17 |
$18.51 |
| Fair Value Estimate |
$192.90 |
$26.84 |
| Upside to Fair Value |
+8.9%
|
+45.0%
|
| Market Cap |
$125.4B |
$8.7B |
| Forward P/E |
34.1x
|
20.3x
|
| EV / EBITDA |
20.8x
|
10.5x
|
| Price / Sales |
5.1x
|
2.9x
|
| Price / FCF |
23.7x
|
10.4x
|
| Revenue Growth YoY |
+3.7%
|
+11.8%
|
| Gross Margin |
60.7%
|
77.8%
|
| Operating Margin |
21.0%
|
20.3%
|
| Return on Equity |
7.1%
|
16.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
9.62%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
The Trade Desk operates a leading demand-side platform in the advertising technology sector, specializing in programmatic ad buying with a strong focus on connected TV, retail media, audio, and international markets. The company benefits from a durable competitive moat driven by founder-led management with over 15 years of continuity, a differentiated open-internet infrastructure, and a dominant …
Accumulation Zones
| Metric |
DHR |
TTD |
| Zone Low |
$144.68 |
$20.13 |
| Zone High |
$163.97 |
$22.81 |
| In Buy Zone? |
No
|
Yes
|